Literature DB >> 5040598

Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis.

S Isacson, I M Nilsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5040598

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN： 0001-5482


× No keyword cloud information.
  24 in total

1.  The role of tranexamic acid in reducing blood loss in total knee replacement.

Authors:  Virender Kumar Gautam; Balaji Sambandam; Shailendra Singh; Prince Gupta; Rajat Gupta; Lalit Maini
Journal:  J Clin Orthop Trauma       Date:  2013-01-25

2.  In vitro stimulation of plasminogen activator release from vein walls by adrenaline.

Authors:  A Kjaeldgaard; M Kjaeldgaard
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

3.  Letter: Thromboembolism and oral contraceptives.

Authors:  B Astedt; S Jeppsson
Journal:  Br Med J       Date:  1974-05-11

4.  Tranexamic acid and fibrinolytic activity of the vessel wall.

Authors:  B Astedt; P Liedholm
Journal:  Experientia       Date:  1974-07-15

5.  Naturally occurring canine nephrotic syndrome is a potentially hypercoagulable state.

Authors:  A Rasedee; B F Feldman; R Washabau
Journal:  Acta Vet Scand       Date:  1986       Impact factor: 1.695

Review 6.  Familial venous thrombosis.

Authors:  J H Winter; A S Douglas
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

7.  Protein C values in coronary artery disease.

Authors:  N T O'Connor; A W Broekmans; R M Bertina
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-03

8.  Thrombosis and oral contraceptives: possible predisposition.

Authors:  B Astedt; S Isacson; I M Nilsson; M Pandolfi
Journal:  Br Med J       Date:  1973-12-15

9.  Antithrombin-3 deficiency in a Dutch family.

Authors:  J van der Meer; E A Stoepman-van Dalen; J M Jansen
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

Review 10.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.